Table 1 Characteristics of 55 patients with pericardial effusion treated by surgery a
Variables | Value |
|---|---|
Age, years; mean (range) | 57 (29 to 82) |
Gender, n (%) | |
Male | 31 (56.4) |
Female | 24 (23.6) |
Malignancy, n (%) | |
Lung cancer | 36 (65.5) |
Hematologic malignancy | 4 |
GI cancer | 5 |
Breast cancer | 6 |
Ovary cancer | 1 |
Thyroid cancer | 1 |
Cardiac sarcoma | 1 |
Thymoma | 1 |
Time to PE after cancer diagnosis. months | 9 (0 to 180) |
Dyspnea, n (%) | 45 (81.8) |
Electrocardiography, n (%) | |
Normal | 23 (41.8) |
Abnormal | 32 (58.2) |
Sinus tachycardia | 20 |
Low voltage | 9 |
Atrial fibrillation | 2 |
APC | 1 |
Cardiac tamponade, n (%) | 28 (50.9) |
Ejection fraction, (%) | 62% (48 to 75) |
Prior pericardiocentesis, n (%) | 15 (27.3) |
Recurrence after pericardiocentesis, n | 8 |
Maximum distance of pericardial space by CT, mm | 32.25 (11.7 to 54.68) |
Concomitant pleural effusion, n (%) | 39 (70.9) |
Mediastinal lymphadenopathy, n (%) | 40 (72.7) |
Prior radiotherapy of the chest, n (%) | 22 (40) |
Pericardial metastasis by CT, n (%) | 20 (36.4) |
Pulmonary thromboembolism, n (%) | 3 (5.5) |
Extrathoracic metastasis, n (%) | 32 (58.2) |